Anticompetitive practices prevent patients from accessing the generic and biosimilar medicines they need.
Congress is currently considering a fix, the Creating and Restoring Equal Access to Equivalent Samples (“CREATES”) Act. Encourage your members of Congress to pass this important bill that will bring down costs and increase patient access to life-saving medicines.
Watch this CBS News story that explains the challenge facing so many Americans, like cancer patient, Pam Holt. You, like Pam, can make a difference.
(Play Video) How critics say drug companies play “games” to stave off generic competitors
Read Article
Contact your lawmaker today and ask them to support the CREATES Act:
By Kristin Murphy, AAM Director, Federal Affairs
